Related Experiment Video

Updated: Aug 9, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Advances in the treatment and prevention of severe viral bronchiolitis

Joseph B Domachowske1, Helene F Rosenberg

  • 1Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Pediatric Annals
|February 8, 2005
PubMed

Insights

Viral bronchiolitis, a significant public health issue, can be prevented in high-risk infants using the RSV-F antibody, palivizumab. Research is ongoing for new antibodies, vaccines, and treatments for this common respiratory infection.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Viral bronchiolitis remains a significant global public health concern.
  • Respiratory Syncytial Virus (RSV) is a primary cause of severe bronchiolitis in infants.
  • Current prevention strategies include passive antibody administration for high-risk populations.

Purpose of the Study:

  • To review the current landscape of RSV-associated bronchiolitis management.
  • To highlight advancements in preventive therapies and ongoing research for novel treatments.
  • To underscore the importance of supportive care in established infections.

Main Methods:

  • Review of existing literature on RSV bronchiolitis.
  • Analysis of current preventive measures, including monoclonal antibody use.
  • Overview of preclinical research into antiviral and anti-inflammatory agents.

Main Results:

  • Palivizumab, a humanized monoclonal anti-RSV-F antibody, effectively prevents severe RSV-associated bronchiolitis in high-risk infants.
  • Development of more potent neutralizing antibodies and vaccines is progressing.
  • Supportive therapy is the current standard for treating established RSV infections.

Conclusions:

  • Passive immunization with palivizumab is a key strategy for preventing severe RSV bronchiolitis in vulnerable infants.
  • Continued research into novel antibodies, vaccines, and therapeutics is crucial for combating RSV.
  • Exploring new antiviral and anti-inflammatory approaches holds promise for future treatment options.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...